noscript

News and Announcements

Novogen CEO interviewed on CommSec

  • Published July 04, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

CommSec released an interview today as part of its Executive Series, featuring Executive Director and CEO, Dr James Garner.

KEY TAKEAWAYS:

  • Tom Piotrowski talks with Dr Garner about Novogen’s business model and the way it is being used to bring to market the best of available cancer treatments.
  • Providing an overview of Novogen’s pipeline.

Dr Garner talked about the next steps for the Company’s lead candidate GDC-0084, a drug to treat Glioblastoma Multiforme. GDC-0084 was licenced from Genentech, and showed great promise in a Phase I clinical trial. A Phase II clinical trial is expected will start later this year.

Request Offer

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now